Company profile: Endocare
1.1 - Company Overview
Company description
- Provider of medical devices and related consumables for cryoablation, developing, manufacturing, and distributing these products.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Endocare
Sensus Healthcare
HQ: United States
Website
- Description: Provider of non-melanoma skin cancer and keloid treatment solutions via SRT-100 Vision, SRT-100+, and SRT-100 devices delivering non-invasive, low-dose Superficial Radiotherapy; includes high-frequency ultrasound imaging and ease of use in outpatient settings. Offers post-surgical keloid radiotherapy to prevent regrowth and a non-surgical alternative to Mohs surgery with a high cure rate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sensus Healthcare company profile →
IDEC Pharmaceuticals
HQ: United States
Website
- Description: Provider of therapy development targeting neurodegenerative, hematologic, and autoimmune diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IDEC Pharmaceuticals company profile →
Olaris
HQ: United States
Website
- Description: Provider of metabolomics and machine learning-based disease diagnosis and treatment solutions, including Olaris CEREBRO for metabolite profiling to identify individual molecular profiles, myOLARIS diagnostics, a suite of in vitro diagnostic products to optimize patient-specific treatments and outcomes, and Biomarkers of Response (BoRs) technology to determine which patients will benefit from specific therapies and reduce adverse events.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Olaris company profile →
Five Prime Therapeutics
HQ: United States
Website
- Description: Provider of cancer treatment biotechnology, discovering and developing novel therapeutic proteins and antibodies by systematically screening all relevant human proteins to find the best for each clinical indication, enabled by its ProScreen Engine for rapid production and screening.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Five Prime Therapeutics company profile →
Modifi Bio
HQ: United States
Website
- Description: Provider of direct DNA modification cancer therapeutics, including orally delivered molecules that selectively kill cancer cells by modifying tumor DNA while preserving healthy cells. Products target cancers with DNA repair defects and MGMT deficiency, with applications in glioblastomas, gliomas, and potentially other MGMT-deficient tumor types.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Modifi Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Endocare
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Endocare
2.2 - Growth funds investing in similar companies to Endocare
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Endocare
4.2 - Public trading comparable groups for Endocare
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →